SCHEMBL2229545

SCHEMBL2229545

C[N+](C)(CC(O)CC(=O)[O-])C(N)=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A16 Q86VW1 1/20 0.72
CPT2 P23786 2/20 0.50
CPT1A P50416 2/20 0.50
MAPT P10636 2/20 0.43
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
CYP1A2 P05177 1/20 0.40
HRH1 P35367 1/20 0.40
CRAT P43155 1/20 0.40
CA4 P22748 2/20 0.39
CA2 P00918 1/20 0.39
CYP2C19 P33261 2/20 0.38
RECQL P46063 1/20 0.38
BBOX1 O75936 1/20 0.33
TP53 P04637 2/20 0.33
CYP2D6 P10635 2/20 0.33
TSHR P16473 2/20 0.33
SLC25A20 O43772 2/20 0.33
CPT1B Q92523 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10630132 0.98 SLC22A16 (0.69) SLC22A16CPT2CPT1AMAPTMEN1
Carnitine SCHEMBL15993950 0.87 SLC22A16 (0.87) SLC22A16CPT2CPT1AMAPTMEN1
Carnitine SCHEMBL1813524 0.84 SLC22A16 (1.00) SLC22A16CPT2CPT1AMAPTMEN1
Levocarnitine SCHEMBL21970 0.84 SLC22A16 (1.00) SLC22A16CPT2CPT1AMAPTMEN1
Levocarnitine SCHEMBL4593172 0.84 SLC22A16 (1.00) SLC22A16CPT2CPT1AMAPTMEN1
Carnitine SCHEMBL21971 0.84 SLC22A16 (1.00) SLC22A16CPT2CPT1AMAPTMEN1
D-Carnitine SCHEMBL94286 0.84 SLC22A16 (1.00) SLC22A16CPT2CPT1AMAPTMEN1
Carnitine SCHEMBL3902633 0.84 SLC22A16 (1.00) SLC22A16CPT2CPT1AMAPTMEN1
Carnitine SCHEMBL17629811 0.84 SLC22A16 (1.00) SLC22A16CPT2CPT1AMAPTMEN1
Carnitine SCHEMBL7881486 0.83 SLC22A16 (0.87) SLC22A16CPT2CPT1AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5994581-A Carnitine creatinate AMT LABS, INC. (US) 1999-11-30 US claimed
US-5238838-A Hydrolysis catalysts converting L-carnitine amide to L-carnitine; stereospecific DEGUSSA AKTIENGESELLSCHAFT (DE) 1993-08-24 US claimed
EP-0056615-B1 PROCESS FOR THE PREPARATION OF CARNITINAMIDE LONZA AG (CH) 1984-06-13 EP claimed
US-4443627-A Process for the production of carnitine amide LONZA LTD. (CH) 1984-04-17 US claimed
JP-56110654-A None JP disclosed
JP-1213259-A None JP disclosed
JP-1213258-A None JP disclosed
JP-60258487-A None JP disclosed
JP-1213258-A None JP disclosed
JP-1213259-A None JP disclosed
JP-4320679-A None JP disclosed
JP-4320679-A None JP disclosed
JP-S60258487-A MANUFACTURE OF CARNITINE OR CARNITINE AMIDE AQUEOUS SOLUTION BASF AG 1985-12-20 JP disclosed
EP-0163222-A1 Process for obtaining aqueous solutions of carnitine amide BASF Aktiengesellschaft (DE) 1985-12-04 EP disclosed
US-4443627-A Process for the production of carnitine amide LONZA LTD. (CH) 1984-04-17 US disclosed
US-4443627-A Process for the production of carnitine amide LONZA LTD. (CH) 1984-04-17 US disclosed
US-4443627-A Process for the production of carnitine amide LONZA LTD. (CH) 1984-04-17 US disclosed
JP-S57140749-A MANUFACTURE OF CARNITINE AMIDE LONZA AG 1982-08-31 JP disclosed
JP-S56110654-A CARNITINE AMIDE DERIVATIVE OF AMINO ACID AND ITS MANUFACTURE SIGMA TAU IND FARMACEUTI 1981-09-01 JP disclosed
JP-S06356294-A 0001-01-01 JP disclosed